Prevalence, Knowledge and Potential Determinants of COVID-19 Vaccine Acceptability Among University Students in the United Arab Emirates: Findings and Implications.

Ajman University COVID-19 acceptance concerns knowledge university student vaccine

Journal

Journal of multidisciplinary healthcare
ISSN: 1178-2390
Titre abrégé: J Multidiscip Healthc
Pays: New Zealand
ID NLM: 101512691

Informations de publication

Date de publication:
2022
Historique:
received: 28 09 2021
accepted: 17 11 2021
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 21 1 2022
Statut: epublish

Résumé

To evaluate the prevalence, knowledge, attitude and acceptance of the COVID-19 vaccines and related factors among university students in the United Arab Emirates. Analytical cross-sectional study undertaken among a convenient sample of medical and non-medical colleges of Ajman University using a self-administrated questionnaire. The questionnaire included demographic data as well as assessing knowledge of COVID-19, attitudes and acceptance of COVID-19 vaccines. A total of 467 students participated in the study and completed the questionnaire. A total of 181 (38.8%) participants reported that they have been vaccinated against COVID-19 virus, principally with the Sinopharm vaccine (84%). Vaccination against the COVID-19 virus was less prevalent among Arabic nationalities compared to other nationalities, but more prevalent among students from health science colleges compared to those from non-health science colleges. The acceptance rate of COVID-19 vaccine among study participants was 56.3%, exacerbated by worries regarding unforeseen problems (65.5%, 306), general mistrust (47.3%, 221) and unforeseen impacts (35.1%, 164). The average knowledge score was 60.1%, with 142 (30.4%) having poor knowledge, 127 (27.2%) acceptable knowledge and 198 (42.4%) good knowledge. There were common misconceptions about symptoms including nausea and diarrhoea, as well as the route of transmission, with half believing antibiotics are effective treatment. There was variable knowledge of COVID-19 among students. Misconceptions need addressing going forward. To enhance COVID-19 vaccination uptake in the country and worldwide, health education targeting diverse sociodemographic categories should be prioritized.

Identifiants

pubmed: 35046663
doi: 10.2147/JMDH.S341700
pii: 341700
pmc: PMC8760974
doi:

Types de publication

Journal Article

Langues

eng

Pagination

81-92

Informations de copyright

© 2022 Shahwan et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest to disclose.

Références

PLoS One. 2021 May 12;16(5):e0251605
pubmed: 33979412
Hum Vaccin Immunother. 2021 Jul 3;17(7):2279-2288
pubmed: 33522405
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Hum Vaccin Immunother. 2021 Mar 8;:1-3
pubmed: 33684019
Z Gesundh Wiss. 2021 May 1;:1-21
pubmed: 33968601
Vaccines (Basel). 2021 Nov 01;9(11):
pubmed: 34835190
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Life (Basel). 2021 Jun 07;11(6):
pubmed: 34200116
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Int J Environ Res Public Health. 2021 Mar 01;18(5):
pubmed: 33804558
Trop Med Health. 2021 May 13;49(1):37
pubmed: 33985592
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Vaccines (Basel). 2021 Oct 06;9(10):
pubmed: 34696249
Vaccines (Basel). 2021 May 29;9(6):
pubmed: 34072500
Nurse Educ Today. 2021 Sep;104:105010
pubmed: 34126322
Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080
pubmed: 32991230
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864
BMJ. 2020 May 18;369:m1983
pubmed: 32423901
Risk Manag Healthc Policy. 2021 Jun 01;14:2253-2261
pubmed: 34104016
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Infect Drug Resist. 2020 Dec 29;13:4673-4695
pubmed: 33402839
PLoS One. 2021 Apr 23;16(4):e0250555
pubmed: 33891660
Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):119-129
pubmed: 33993823
Appl Health Econ Health Policy. 2021 Jul;19(4):623-624
pubmed: 33973149
J Community Health. 2020 Oct;45(5):881-890
pubmed: 32318986
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Pharmaceuticals (Basel). 2021 Oct 15;14(10):
pubmed: 34681273
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccines (Basel). 2020 Dec 06;8(4):
pubmed: 33291245
Vaccines (Basel). 2021 Oct 25;9(11):
pubmed: 34835174
Vaccines (Basel). 2021 Aug 25;9(9):
pubmed: 34579180
Elife. 2021 May 27;10:
pubmed: 34042047
Front Pharmacol. 2021 Jan 14;11:588106
pubmed: 33628173
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802285
J Community Health. 2021 Dec;46(6):1244-1251
pubmed: 33877534
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Health Expect. 2021 May 11;:
pubmed: 33974721
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478623
Int J Environ Res Public Health. 2021 Jul 25;18(15):
pubmed: 34360156
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Front Med (Lausanne). 2021 Mar 01;8:644300
pubmed: 33732723
J Infect Dev Ctries. 2020 Aug 31;14(8):838-843
pubmed: 32903226
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
Vaccines (Basel). 2021 Oct 09;9(10):
pubmed: 34696261
Eur J Epidemiol. 2020 Aug;35(8):781-783
pubmed: 32761440
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Vaccines (Basel). 2021 Apr 13;9(4):
pubmed: 33924604
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Vaccines (Basel). 2021 Jul 22;9(8):
pubmed: 34451939
Front Public Health. 2021 Jul 26;9:614499
pubmed: 34381748
Front Public Health. 2021 Apr 21;9:626852
pubmed: 33968880
JAMA. 2020 Aug 4;324(5):441-442
pubmed: 32749495
Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593
pubmed: 32693678
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
Int J Environ Res Public Health. 2021 May 12;18(10):
pubmed: 34065888
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
PLoS One. 2021 Jan 14;16(1):e0245176
pubmed: 33444360
Med Sci Monit. 2020 Nov 01;26:e928996
pubmed: 33177481
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
Vaccines (Basel). 2021 Jul 07;9(7):
pubmed: 34358173
Am J Trop Med Hyg. 2020 Aug;103(2):603-604
pubmed: 32588810
Infect Drug Resist. 2011;4:197-207
pubmed: 22114512
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
Appl Health Econ Health Policy. 2021 May;19(3):343-351
pubmed: 33619688
J Community Health. 2021 Jun;46(3):457-470
pubmed: 32638198
BMJ. 2020 Aug 13;370:m3205
pubmed: 32816758
Vaccine. 2021 Jan 8;39(2):247-254
pubmed: 33328140
J Med Virol. 2021 Jul;93(7):4280-4291
pubmed: 33644891
Appl Health Econ Health Policy. 2021 Jul;19(4):619-621
pubmed: 33973148
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
BMC Public Health. 2021 Oct 13;21(1):1851
pubmed: 34645399
Vaccines (Basel). 2021 Sep 02;9(9):
pubmed: 34579218
Lancet. 2020 Sep 26;396(10255):870-871
pubmed: 32919522

Auteurs

Moyad Shahwan (M)

College of Pharmacy and Health Science, Ajman University, Ajman, United Arab Emirates.
Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

Abdulhaq Suliman (A)

Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
College of Dentistry, Ajman University, Ajman, United Arab Emirates.

Ammar Abdulrahman Jairoun (A)

Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Sahib Alkhoujah (S)

College of Pharmacy and Health Science, Ajman University, Ajman, United Arab Emirates.

Sabaa Saleh Al-Hemyari (SS)

Pharmacy Department, Emirates Health Services, Dubai, United Arab Emirates.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Saleh Karamah Al-Tamimi (SK)

Faculty of Pharmacy, Aden University, Aden, Yemen.

Brian Godman (B)

Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, UK.
Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Ramzi A Mothana (RA)

Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Classifications MeSH